Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pleural Mesothelioma (MPM)”

Showing 18 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00770120
What this trial is testing

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 61
Testing effectiveness (Phase 2)Study completedNCT00334594
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 153
Early research (Phase 1)Looking for participantsNCT03760575
What this trial is testing

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesotheliomas Pleural
Abramson Cancer Center at Penn Medicine 20
Large-scale testing (Phase 3)Study completedNCT02709512
What this trial is testing

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Mesothelioma
Polaris Group 249
Large-scale testing (Phase 3)Study completedNCT02991482
What this trial is testing

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT02153229
What this trial is testing

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Who this might be right for
Epitheliod Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 52
Not applicableLooking for participantsNCT06037941
What this trial is testing

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT03762018
What this trial is testing

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 400
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Not applicableLooking for participantsNCT07561190
What this trial is testing

Multidimensional Omics Analysis in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
Azienda USL Reggio Emilia - IRCCS 300
Not applicableUnknownNCT05042557
What this trial is testing

Real World Study of MPM in China

Who this might be right for
Malignant Pleural MesotheliomaDiagnoses DiseaseTreatments+1 more
Chinese Academy of Medical Sciences 500
Early research (Phase 1)Active Not RecruitingNCT04577326
What this trial is testing

Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Study completedNCT01358084
What this trial is testing

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

Who this might be right for
Advanced Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 137
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Not applicableStudy completedNCT05324436
What this trial is testing

Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 75
Testing effectiveness (Phase 2)Study completedNCT02716272
What this trial is testing

Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 125
Testing effectiveness (Phase 2)Study completedNCT00700336
What this trial is testing

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Who this might be right for
Malignant Pleural MesotheliomaSolid Tumors
CanBas Co. Ltd. 69

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation